Preclinical evaluation of a next-generation, subcutaneously administered, coagulation factor IX variant, dalcinonacog alfa

• Timothy C. Nichols,

  Roles Conceptualization, Investigation, Methodology, Project administration, Resources, Supervision, Writing – original draft

  Affiliation Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• Howard Levy ,

  Roles Conceptualization, Funding acquisition, Methodology, Resources, Visualization, Writing – original draft

  * E-mail: hlevy@catbio.com

  Affiliation Catalyst Biosciences, South San Francisco, California, United States of America

  ⨯
• Elizabeth P. Merricks,

  Roles Investigation

  Affiliation Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• Robin A. Raymer,

  Roles Investigation

  Affiliation Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• Martin L. Lee

  Roles Formal analysis

  Affiliation Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles, California, United States of America

  ⨯